Corteva, Inc. (CTVA) earnings on July 30, 2026
Prior outlook: No statistical edge
Corteva's stock fell sharply despite reporting better-than-expected profit and raising its outlook, because sales came in below what analysts had hoped for.
CTVA price around the earnings
78.71
Change: -12.2%
2026-07-31, 20:00 UTC
Start of the measured window
End of the measured window
78.71
82.47
86.22
89.98
89.60
July 30, 2026
July 31, 2026
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- No trading (market closed)
- Starting price
Prior thesis
Prior outlook: No statistical edge
- Thesis published
- Results released
Buy-rated with 75% beat history but price below support and minimal upside; trajectory weakening.
Context analyzed before publication
- Trend
- Positive trend strength with analyst upgrades, but recent trajectory weakening and price below support.
Analysts
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 1.81
- Analysts covering the stock
- 20
- Average price target
- 91.4
- Lowest price target
- 77
- Highest price target
- 103
- Upside to price target
- 1.9%
- Quarterly earnings growth
- 10.4%
- Revenue growth
- 11%
- Forward EPS
- 4.14
- Trailing EPS
- 1.85
- Analyst moves in the last 60 days
- 7
- Strong buy: 3
- Buy: 11
- Hold: 7
- Sell: 0
- Strong sell: 0
- Strong buy
- 3
- Buy
- 11
- Hold
- 7
- Sell
- 0
- Strong sell
- 0
- July 23, 2026 · Oppenheimer: Maintains rating (Outperform → Outperform)
- July 21, 2026 · RBC Capital: Maintains rating (Outperform → Outperform)
- July 20, 2026 · B of A Securities: Maintains rating (Buy → Buy)
- July 14, 2026 · Mizuho: Maintains rating (Outperform → Outperform)
- July 2, 2026 · Mizuho: Maintains rating (Outperform → Outperform)
- June 11, 2026 · Barclays: Maintains rating (Overweight → Overweight)
- June 9, 2026 · UBS: Maintains rating (Neutral → Neutral)
News and sentiment
Evidence
Sentiment
- Sentiment
- Constructive
- Mention volume
- Low
- Normalized volume
- 33%
News
Sources (8)
- Watching Corteva; Hearing Zacks Surprise Trader Buys Stock (opens in a new tab) — Benzinga
- Oppenheimer Maintains Outperform on Corteva, Raises Price Target to $95 (opens in a new tab) — Benzinga
- RBC Capital Maintains Outperform on Corteva, Raises Price Target to $103 (opens in a new tab) — Benzinga
- B of A Securities Maintains Buy on Corteva, Raises Price Target to $96 (opens in a new tab) — Benzinga
- Mizuho Maintains Outperform on Corteva, Raises Price Target to $97 (opens in a new tab) — Benzinga
- New York Attorney General's Suit Names 3M, Chemours, Corteva, DuPont De Nemours; New York Attorney General Sues Chemical Companies Over Alleged Toxic Pollution from Consumer Products (opens in a new tab) — Benzinga
- Reported Friday, Corteva To Integrate Arevo's Arginex Soy Seed Treatment, Designed To Strengthen Root Systems And Increase Soybean Nodulation (opens in a new tab) — Benzinga
- Mizuho Maintains Outperform on Corteva, Raises Price Target to $96 (opens in a new tab) — Benzinga
Technicals
Evidence
- Price when the context was analyzed
- 90.47
- Average true range (ATR)
- 2.1%
- Distance to 52-week high
- -0.9%
- 14-day change (14d)
- +7.1%
- 30-day change (30d)
- +8.4%
- 30-day relative strength
- +10.0%
- SPY change (30d)
- -1.5%
- Nearest support
- 90.02
- Distance to nearest support
- 0.5%
- Nearest resistance
- 91.8
- Distance to nearest resistance
- 1.5%
- Volume accumulation ratio (14d / 46d)
- 0.79
- Mid: 90.02 (0.5% away, 0.24 ATR, 9 touches)
- Minor: 89.33 (1.3% away, 0.61 ATR, 4 touches)
- Minor: 88.47 (2.2% away, 1.07 ATR, 7 touches)
- Mid: 91.8 (1.5% away, 0.71 ATR, 6 touches)
Trends
Evidence
- Average earnings surprise
- +23.3%
- May 5, 2026: actual EPS 1.5 vs estimate 1.18 (surprise +27.1%)
- February 3, 2026: actual EPS 0.22 vs estimate 0.22 (surprise -1.6%)
- November 4, 2025: actual EPS -0.23 vs estimate -0.47 (surprise +50.6%)
- August 6, 2025: actual EPS 2.2 vs estimate 1.88 (surprise +17.1%)
Expected move
- Implied move
- +1.7%
- Source
- Options chain
Reactions over its last 20 earnings
- Median move
- 3.2%
- 75th percentile move
- 5.5%
- 90th percentile move
- 7.2%
- Up / down moves
- 10 / 10
- Average up move
- +5.4%
- Average down move
- -3.0%
Monitoring and close
What Corteva, Inc. reported
- Status
- Finished
| Actual EPS | 2.3 |
|---|---|
| EPS estimate | 2.22 |
| EPS surprise | +3.6% |
| Revenue | $6,379 million |
| Revenue estimate | $6,582 million |
| Revenue surprise | -3.1% |
Corteva beat earnings estimates in Q2, but revenue fell short. The company raised its 2026 guidance, reflecting optimism.
Sources (6)
- Corteva, Inc. (CTVA) Reports Q2 Earnings: What Key Metrics Have to Say (opens in a new tab) — Zacks
- Corteva, Inc. (CTVA) Q2 Earnings Beat Estimates (opens in a new tab) — Zacks
- Corteva Raises FY2026 Adj EPS Guidance from $3.45-$3.70 to $3.60-$3.80 vs $3.75 Est (opens in a new tab) — Benzinga
- Corteva reported adjusted earnings of $2.30 per share, beating the $2.22 estimate, but revenue of $6.379B missed the $6.582B forecast. — Benzinga
- Corteva Q2 Adj. EPS $2.30 Beats $2.22 Estimate, Sales $6.379B Miss $6.582B Estimate (opens in a new tab) — Benzinga
- Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation (opens in a new tab) — Yahoo
Pre-market second reading after the results
- Verdict
- Mixed results
Heading into the open, results beat expectations on earnings but not on revenue, and the price is indicating -4.8% pre-market, a move above the stock's usual reaction (about 3%). The figures don't confirm the prior scenario: there was no prior directional scenario to check against.
How the stock reacted
- Consolidated
- -11.6%
- Max move
- -12.2%
No verdict: the outlook took no direction, so there is nothing to score as a hit or a miss.